Share this article
Share this article
NEW YORK, March 15, 2021 /PRNewswire/ The extracorporeal membrane oxygenation machine market is estimated to cross
USD 307.5 million by 2028 according to a new study conducted by Polaris Market Research. the market is
anticipated to register a CAGR of 5.3% from
2021 – 2028
. A rise in the number of hospitals providing ECMO services and an increase in the number of awareness campaigns to boost its adoption are some of the key factors fueling the market growth. The growth of the market is also attributed to the
increasing prevalence of cardiovascular and respiratory diseases along with the increasing adoption rate of ECMO for lung transplantation. In addition to this, the growing geriatric population, improving healthcare infrastructure, and rise in the rate of people struggling from diseases, especially in populous countries such as India and China are projected to offer lucrative growth opportunities for the market players.